Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort.

I Greeve; Johann Sellner; T Lauterburg; U Walker; K M Rösler; H P Mattle

doi:10.1111/j.1600-0404.2007.00872.x

Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort.

I Greeve, Johann Sellner (Co-author), T Lauterburg, U Walker, K M Rösler, H P Mattle

Research output: Contribution to journal › Original Article › peer-review

11 Citations (Web of Science)

Original language	English
Pages (from-to)	207-210
Journal	ACTA NEUROLOGICA SCANDINAVICA
Volume	116
Issue number	4
DOIs	https://doi.org/10.1111/j.1600-0404.2007.00872.x
Publication status	Published - 2007

Keywords

GLYCOSYLATED NATIVE MOG
1ST DEMYELINATING EVENT
DIAGNOSIS

Access to Document

10.1111/j.1600-0404.2007.00872.x

Cite this

Greeve, I., Sellner, J., Lauterburg, T., Walker, U., Rösler, K. M., & Mattle, H. P. (2007). Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. ACTA NEUROLOGICA SCANDINAVICA , 116(4), 207-210. https://doi.org/10.1111/j.1600-0404.2007.00872.x

Greeve, I ; Sellner, Johann ; Lauterburg, T et al. / Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. In: ACTA NEUROLOGICA SCANDINAVICA 2007 ; Vol. 116, No. 4. pp. 207-210.

@article{6c650f03977b466ca012ab16fa9e6d95,

title = "Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort.",

keywords = "GLYCOSYLATED NATIVE MOG, 1ST DEMYELINATING EVENT, DIAGNOSIS",

author = "I Greeve and Johann Sellner and T Lauterburg and U Walker and R{\"o}sler, \{K M\} and Mattle, \{H P\}",

note = "all: Department of Neurology, Inselspital, University Hospital Bern, Bern, Switzerland",

year = "2007",

doi = "10.1111/j.1600-0404.2007.00872.x",

language = "English",

volume = "116",

pages = "207--210",

journal = "ACTA NEUROLOGICA SCANDINAVICA ",

issn = "0001-6314",

number = "4",

}

Greeve, I, Sellner, J, Lauterburg, T, Walker, U, Rösler, KM & Mattle, HP 2007, 'Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort.', ACTA NEUROLOGICA SCANDINAVICA , vol. 116, no. 4, pp. 207-210. https://doi.org/10.1111/j.1600-0404.2007.00872.x

Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. / Greeve, I; Sellner, Johann (Co-author); Lauterburg, T et al.
In: ACTA NEUROLOGICA SCANDINAVICA , Vol. 116, No. 4, 2007, p. 207-210.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort.

AU - Greeve, I

AU - Sellner, Johann

AU - Lauterburg, T

AU - Walker, U

AU - Rösler, K M

AU - Mattle, H P

N1 - all: Department of Neurology, Inselspital, University Hospital Bern, Bern, Switzerland

PY - 2007

Y1 - 2007

KW - GLYCOSYLATED NATIVE MOG

KW - 1ST DEMYELINATING EVENT

KW - DIAGNOSIS

U2 - 10.1111/j.1600-0404.2007.00872.x

DO - 10.1111/j.1600-0404.2007.00872.x

M3 - Original Article

C2 - 17824895

SN - 0001-6314

VL - 116

SP - 207

EP - 210

JO - ACTA NEUROLOGICA SCANDINAVICA

JF - ACTA NEUROLOGICA SCANDINAVICA

IS - 4

ER -

Greeve I, Sellner J, Lauterburg T, Walker U, Rösler KM, Mattle HP. Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort. ACTA NEUROLOGICA SCANDINAVICA . 2007;116(4):207-210. doi: 10.1111/j.1600-0404.2007.00872.x